M. Wierzbicki

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome

J Słowińska-Srzednicka, S Zgliczyński, M. Wierzbicki et al. · Journal of Endocrinological Investigation · 1991 · 70 citations

Metabolic Disorder, Gynecology, Polycystic Ovary Syndrome +16

Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.

M. Wierzbicki, Adrian Chabowski, Małgorzata Żendzian‐Piotrowska et al. · PubMed · 2009 · 28 citations

Lipid Peroxidation, Fatty Liver Disease, Oxidative Stress +18

Effect of clonidine on beta-endorphin, ACTH and cortisol secretion in essential hypertension and obesity

J Słowińska-Srzednicka, S Zgliczyński, Piotr Soszyński et al. · European Journal of Clinical Pharmacology · 1988 · 17 citations

Obesity, Metabolic Syndrome, Hypertension +12

Chronic, in vivo, PPARα activation prevents lipid overload in rat liver induced by high fat feeding

M. Wierzbicki, Adrian Chabowski, Małgorzata Żendzian‐Piotrowska et al. · Advances in Medical Sciences · 2009 · 17 citations

Metabolic Syndrome, Nutrition, Lipid Synthesis +11

S15261, a new compound for the treatment of the insulin resistance syndrome

J Duhault, F. Lacour, M. Boulanger et al. · Diabetologia · 1994 · 15 citations · Full text

Metabolic Syndrome, Medicinal Chemistry, Diabetes Management +11